TRAMPLE

TRAMPLE predicts and annotates transmembrane protein sequences, including alpha-helical and beta-strand (beta-barrel) segments, signal peptides, secondary structure, and membrane topology to support membrane protein characterization.

Key Features:

• Transmembrane Segment Prediction: Predicts both alpha-helical and beta-strand transmembrane segments.
• Neural Network with Evolutionary Profiles: Applies neural network-based methodologies that leverage evolutionary profiles as input to improve prediction accuracy.
• Signal Peptide Detection: Detects signal peptides for subcellular targeting.
• Secondary Structure Prediction: Predicts secondary structure elements to inform folding and functional inference.
• Topology Determination: Predicts orientation and topology of transmembrane helices (HTMs), including analysis of positively charged residues that are more abundant in extra-cytoplasmic regions.
• Model Optimization and Accuracy: Employs dynamic programming-like algorithms to optimize predictions and reports up to 78% residue accuracy for beta-strand topography when evolutionary information is used.
• HMM Integration: Integrates hidden Markov models (HMM) with neural network approaches for topology prediction.
• Validation: Validated using cross-validation and double-blind test sets.

Scientific Applications:

• Membrane Protein Annotation: Supports annotation of membrane protein topology and secondary structure, including cases lacking homologous sequences in existing databases.
• Proteome Analysis: Enables proteome-wide identification and characterization of outer membrane proteins, including beta-barrel structures.
• Integral Membrane Protein Research: Facilitates studies of orientation, location, function, and interactions of integral membrane proteins.

Methodology:

Integrates neural network-based approaches with hidden Markov models (HMM), uses evolutionary profiles/information as input, optimizes predictions via dynamic programming-like algorithms, and validates performance by cross-validation and double-blind test sets.